C&CB Seminar - Dr. Aline Cerf, University of Toulouse, France
TITLE: Methods and devices for the isolation and analysis of circulating cancer biomarkers in clinical routines.
DATE: Tuesday May 21, 2019
TIME: 1:30 p.m.
LOCATION: ABB 165
HOST: Dr. Jose Moran-Mirabal
Methods and devices for the isolation and analysis of circulating cancer biomarkers in clinical routines.
Dr. Aline Cerf, Directeur de Recherche, Engineering in Life Sciences Applications Group, LAAS-CNRS, Toulouse, France
A huge bottleneck in assigning and delivering cancer treatments is the diagnosis and disease progression monitoring in response to treatment. Liquid biopsies, including among others circulating cell-free DNA (cfDNA) and circulating tumor cells (CTCs), are new non-invasive strategies to detect and monitor cancer in the era of precision medicine and immunotherapy. In this talk I will introduce two recent developments based on micro/nanotechnologies for the isolation of molecular and cellular biomarkers from whole unprocessed blood in clinical routine.
Bio: Dr. Aline Cerf received her PhD in Nanophysics from the University of Toulouse in 2010. Dr. Cerf was a postdoctoral fellow of the Craighead’s lab at Cornell University from 2010 to 2012. In 2012, she joined the French National Center for Scientific Research (CNRS) as a research scientist. Her research activities involve using micro- and nanotechnologies to develop new tools and devices for life science and medical applications. In particular, she has a strong expertise in biopatterning and 3D additive manufacturing. She is also co-founder, associate and chief scientific officer of a start-up company (SmartCatch®) developing medical devices for oncology.